Research Journal of Cell Sciences
Regulating Nystagmus and Saccadic Eye Movements via DNA+Graphene+ Isotope Hybrid Computation at the Brain-CSF Interface
Abstract
Chur Chin
Nystagmus and saccadic eye movement dysfunctions are debilitating neurological conditions affecting visual stability and gaze control [1]. Current treatments often offer limited efficacy due to their inability to precisely address underlying neural dysregulation. This paper proposes a novel neuro-computational framework for the real-time regulation of nystagmus and saccadic eye movements. Our approach integrates artificial intelligence (AI) with a DNA+ graphene+ radioisotope hybrid computational interface strategically positioned at the brain-cerebrospinal fluid (CSF) junction. This advanced interface, leveraging the unique properties of each component, would enable highly localized, high-bandwidth signal processing and transmission [2-5]. The system aims to interpret abnormal eye movement patterns, predict desired corrective actions, and deliver targeted neural stimulation to the oculomotor (III), trochlear (IV), and abducens (VI) cranial nerves, or their associated brainstem nuclei [5]. Crucially, the incorporation of radioisotopes allows for dynamic regulation of CSF flow regimes (laminar and turbulent) to optimize quantum-gravitational information processing, enhancing signal fidelity and computational complexity within the neurofluidic environment [6-8]. Proprioceptive feedback from extraocular muscles (EOMs) will be continuously analyzed by the AI to iteratively refine neural commands, ensuring adaptive and precise ocular stabilization [9,10]. This interdisciplinary approach, combining nanobiotechnology, advanced AI, and neurofluidics [4,7,11] offers a promising avenue for precise and adaptive therapeutic intervention for complex ocular motility disorders.